SK bioscience inked a manufacturing deal with MSD for an Ebola vaccine candidate.
Under the contract manufacturing organization (CMO) deal, the New Jersey-based company will transfer technology for the candidate to SK bioscience so that the Korean company can make it at the L House, its vaccine manufacturing site in Andong, North Gyeongsang.
Despite AI’s impressive track record, its computational power pales in comparison with that of the human brain. Scientists unveil a revolutionary path to drive computing forward: organoid intelligence (OI), where lab-grown brain organoids serve as biological hardware. “This new field of biocomputing promises unprecedented advances in computing speed, processing power, data efficiency, and storage capabilities – all with lower energy needs,” say the authors in an article published in Frontiers in Science.
Artificial intelligence (AI) has long been inspired by the human brain. This approach proved highly successful: AI boasts impressive achievements – from diagnosing medical conditions to composing poetry. Still, the original model continues to outperform machines in many ways. This is why, for example, we can ‘prove our humanity’ with trivial image tests online. What if instead of trying to make AI more brain-like, we went straight to the source?
The development demonstrates that China is allegedly at the forefront of the “white-hot technology war between China and the US,” claims Chinese state-run media.
This development encourages the application of brain science research and demonstrates that China is allegedly at the forefront of the “white-hot technology war between China and the US,” according to Chinese state-run media reports on Friday evening.
Chinese researchers claim to have successfully conducted the “world’s first” brain-computer interface (BCI) experiment on a monkey, showcasing China’s BCI technological breakthrough.
Continue reading “China syncs monkey brain with a computer in a ‘world first’ experiment” »
Artificial intelligence-powered BacterAI accurately predicts the necessary amino acid combinations for growth 90% of the time.
A group of scientists has created a system powered by artificial intelligence (AI) that enables robots to conduct as many as 10,000 scientific experiments independently in a single day.
The AI system, named BacterAI, could significantly accelerate the pace of discovery in a range of fields such as medicine, agriculture, and environmental science. In a recent research study released in Nature Microbiology, the team successfully utilized BacterAI to map the metabolic processes of two microbes linked with oral health.
I suspected both this and alzheimers are bacterial infections.
A common genus of microbe found in wet, boggy environments could play a key role in the development of Parkinson’s disease, by excreting compounds that trigger proteins inside brain cells to form toxic clumps.
The findings, made by a small team of researchers at the University of Helsinki and the University of Eastern Finland, build on the results of an earlier investigation showing that the severity of the neurodegenerative disorder in volunteers increased with concentrations of Desulfovibrio bacterial strains in their feces.
Continue reading “Parkinson’s May Be Caused by a Common Aquatic Bacterium” »
Stinging of Hymenoptera can induce IgE-mediated hypersensitivity reactions in patients with venom allergies, ranging from local to severe systemic reactions and even fatal anaphylaxis. Allergic patients’ quality of life can be primarily improved by injecting increased venom doses to alter their immune response to tolerate venom. This venom-specific immunotherapy is very effective and well tolerated, especially in the administration of vaccines. Creative Biolabs is a world leader in the field of vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for allergic disease.
Creative Biolabs provides vaccine development services for bee venom allergy according to customer’s detailed requirements.
Learn about the causes, symptoms, diagnosis & treatment from the MSD Manuals — Medical Consumer Version.
In a study of 17 people from five families, Johns Hopkins Medicine researchers say they found that ultra-lengthy DNA endcaps called telomeres fail to provide the longevity presumed for such people. Instead, people with long telomeres tend to develop a range of benign and cancerous tumors, as well as the age-related blood condition clonal hematopoiesis.
Reporting in the May 4 issue of the New England Journal of Medicine, the Johns Hopkins researchers say clonal hematopoiesis is common among this long-telomere group, and the blood condition combined with long telomeres may help mutations stick around longer in blood cells.
“Our findings challenge the idea that long telomeres protect against aging,” says Mary Armanios, M.D., professor of oncology at the Johns Hopkins Kimmel Cancer Center, and professor of genetic medicine, molecular biology and genetics, and pathology at the Johns Hopkins University School of Medicine. “Rather than long telomeres protecting against aging, long telomeres allowed cells with mutations that arise with aging to be more durable.”
The immune system has a biological telecommunications system—small proteins known as interleukins that send signals among the leukocyte white blood cells to control their defense against infections or nascent cancer. Interleukin-6, or IL-6, is one of these key mediators of inflammation, and it can, as needed, provoke the immune system into attack against pathogens.
However, imbalances of IL-6—too much or too little—can cause disease, even in the absence of infection. Excess IL-6 is central to the pathogenesis of inflammatory reactions like rheumatoid disease and cytokine storms, while mutations that interrupt IL-6 signaling are also harmful, causing allergic disorders known as atopy that affect the skin, airways or body, including atopic dermatitis, allergic airway inflammation and hyper-IgE Syndrome, or HIES.
Loss of IL-6 signaling was known to cause an increase in inflammatory T helper 2, or Th2, cells. T helper cells act like generals, ordering other immune cells into action. Now, an unrecognized mechanism of how interrupted IL-6 signaling creates Th2 bias, as well as the specific role of IL-6 signaling in that process, has been described by Beatriz Léon, Ph.D., and colleagues at the University of Alabama at Birmingham. Their study is published in Cellular & Molecular Immunology.
The xenobot had been predicted to be a valuable tool in medicine and other fields. It is expected not only to help treat cancer but keep the aquatic bodies clean.
Ever imagined a world where we could utilize the power of a living cell to carry out certain functions? Just like we have robots that help in several aspects of our lives, some scientists in US universities have come up with a living robot known as the xenobot.
The xenobot had been predicted to be a valuable tool in medicine and other fields. In years to come, it wouldn’t only help treat cancer, but it would help keep the aquatic bodies clean.
